Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ComaDopa: 18F-LBT-999 PET in Traumatic Coma
NCT06930261Phase 2Recruiting
- Sponsor
- Inserm
- Start
- Jan 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18f-lbt-999 in coma due to traumatic brain injury, traumatic brain injury (TBI), sponsored by Inserm. Started Jan 2025; status: recruiting.
02
Drugs
18f-lbt-999
03
Conditions
coma due to traumatic brain injurytraumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06930261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06930261.